We’ve done this using a modified version of Agilent SureSelect XT, but Twist also good.

@sptlabtech.bsky.social and Agilent Technologies have introduced automated targeted enrichment protocols for genomic workflows. The protocols on SPT Labtech’s firefly+ platform use Agilent’s SureSelect Max DNA Library Prep Kits to increase reproducibility and reduce costs: tinyurl.com/5fmtwuf5

📢 Now free and on demand!

Who says you can’t have it all? Discover how one NGS assay delivers rapid, comprehensive profiling for ALL hematologic malignancies.

Speaker: Sean Glenn, Ph.D., co-developer of the SureSelect Cancer Pan Heme Assay

www.amp.org/educatio...

#diagnostics #colorectalcancer #Tagomics #colorectalcancertest #Biotech #NHS #InnovateUK #BiomedicalCatalystprogramme #Interlaceplatform #biomarkers #epigeneticmarkers #epigeneticprofiling #multiomicworkflow #AgilentTechnologies #SureSelect #multiomicprofiling
pharmatimes.com/news/tagomic...

New preprint on our work using SureSelect target enrichment to sequence N. gonorrhoeae direct from sample www.medrxiv.org/content/10.1...

⏳Less hands-on time. Faster insights. More confidence in your data. This application note walks through how AVITI™ integrates into a complete CGP workflow alongside Agilent SureSelect and SeqOne.

🔗 Get the app note: https://bit.ly/4dq0BHo.

#AVITI #NextGenSequencing #ClinicalResearch

We’re partnering with @Agilent to deliver deeper insights from targeted sequencing. Combining SureSelect with long Oxford Nanopore reads, researchers can improve phasing and resolve complex variants — critical for cancer genomics.

Learn more: https://bit.ly/41Mk2mX

Now free & on demand: "Who Says You Can't Have It All: Rapid Comprehensive Molecular Profiling of Hematological Malignancies" featuring Sean Glenn, Ph.D., of Roswell Park Comprehensive Cancer Center, co-developer of the SureSelect Cancer Pan Heme Assay.

www.amp.org/educatio...

📢 Free Webinar | 🗓️ July 29

Who says you can’t have it all? Discover how one NGS assay delivers rapid, comprehensive profiling for ALL hematologic malignancies.

Speaker: Sean Glenn, Ph.D., co-developer of the SureSelect Cancer Pan Heme Assay

Register: us06web.zoom.us/webi...

📅 Free webinar July 29 at 11 a.m. Eastern featuring Sean Glenn, Ph.D., co-developer of the SureSelect Cancer Pan Heme Assay.

👉 Register now: us06web.zoom.us/webi...

REMARKABLE #SureSelect-based enrichment of Salmonella transcripts from infected human cells for Dual RNA-seq @Agilent

Project led by @AnnaAulicino85 from Alison Simmons lab @wimm & co-authors @twitt_lore @GiorgioNapolit9 @anasgeros + Rory Bowden...